Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis
- 1 May 1998
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 38 (5) , 705-711
- https://doi.org/10.1016/s0190-9622(98)70594-8
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Safety, efficacy and duration of therapeutic effect of tazarotene used in the treatment of plaque psoriasisBritish Journal of Dermatology, 1996
- Tazarotene-first of a new generation of receptor-selective retinoidsBritish Journal of Dermatology, 1996
- Response of psoriasis to a new topical retinoid, AGN 190168Journal of the American Academy of Dermatology, 1994
- Hypothalamus-pituitary-adrenal axis suppression by superpotent topical steroidsJournal of the American Academy of Dermatology, 1993
- Continuing medical education (Therapy)Journal of the American Academy of Dermatology, 1987
- SYSTEMIC REACTIONS TO TOPICALLY APPLIED DRUGSInternational Journal of Dermatology, 1978
- Tachyphylaxis to Topically Applied SteroidsArchives of Dermatology, 1976
- Planning the size and duration of a clinical trial studying the time to some critical eventJournal of Chronic Diseases, 1974
- CORTICOSTEROID-INDUCED ATROPHY OF THE SKIN WITH TELANGIECTASIA.British Journal of Dermatology, 1972
- Wasting of napkin area after repeated use of fluorinated steroid ointment.BMJ, 1970